DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,115 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $100,591,000 | -14.8% | 342,921 | -4.4% | 0.54% | -8.1% |
| Q4 2021 | $118,006,000 | +4.1% | 358,671 | -3.7% | 0.59% | -5.8% |
| Q3 2021 | $113,335,000 | +4.4% | 372,280 | -8.0% | 0.63% | +8.5% |
| Q2 2021 | $108,576,000 | +9.3% | 404,595 | -8.4% | 0.58% | -1.4% |
| Q1 2021 | $99,380,000 | +57.7% | 441,540 | +7.8% | 0.58% | +52.7% |
| Q4 2020 | $63,018,000 | +3.3% | 409,468 | +44.5% | 0.38% | -2.8% |
| Q3 2020 | $61,011,000 | +68.5% | 283,337 | +38.4% | 0.39% | +61.5% |
| Q2 2020 | $36,210,000 | +98.4% | 204,778 | +55.3% | 0.24% | +63.8% |
| Q1 2020 | $18,251,000 | -17.9% | 131,864 | -9.0% | 0.15% | -1.3% |
| Q4 2019 | $22,228,000 | +52.1% | 144,827 | +43.1% | 0.15% | +32.5% |
| Q3 2019 | $14,615,000 | -2.1% | 101,183 | -3.1% | 0.11% | -3.4% |
| Q2 2019 | $14,926,000 | +9.2% | 104,438 | +0.9% | 0.12% | +10.3% |
| Q1 2019 | $13,666,000 | +1656.6% | 103,510 | +1271.9% | 0.11% | +1428.6% |
| Q4 2018 | $778,000 | -5.1% | 7,545 | 0.0% | 0.01% | +16.7% |
| Q3 2018 | $820,000 | +24.4% | 7,545 | +13.0% | 0.01% | +20.0% |
| Q2 2018 | $659,000 | +21.1% | 6,677 | +20.2% | 0.01% | +25.0% |
| Q1 2018 | $544,000 | +3.8% | 5,554 | -1.6% | 0.00% | 0.0% |
| Q4 2017 | $524,000 | -97.3% | 5,645 | -97.5% | 0.00% | -96.7% |
| Q3 2017 | $19,170,000 | +710.6% | 223,481 | +697.7% | 0.12% | +454.5% |
| Q2 2017 | $2,365,000 | -53.8% | 28,016 | -53.2% | 0.02% | -55.1% |
| Q1 2017 | $5,120,000 | +4.8% | 59,869 | -4.6% | 0.05% | +6.5% |
| Q4 2016 | $4,887,000 | -35.9% | 62,787 | -35.5% | 0.05% | -36.1% |
| Q3 2016 | $7,627,000 | -25.6% | 97,286 | -27.3% | 0.07% | -25.8% |
| Q2 2016 | $10,246,000 | -15.9% | 133,862 | +4.2% | 0.10% | -17.1% |
| Q1 2016 | $12,183,000 | – | 128,423 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |